Viewing Study NCT01682902


Ignite Creation Date: 2025-12-25 @ 3:46 AM
Ignite Modification Date: 2025-12-26 @ 2:32 AM
Study NCT ID: NCT01682902
Status: COMPLETED
Last Update Posted: 2017-01-09
First Post: 2012-08-31
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Randomised Trial Evaluating Continuous Subcutaneous Infusion of Formulations of NN1218 and NovoLogĀ® in Subjects With Type 1 Diabetes
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module